Contraction-induced interleukin-6 transcription in rat slow-type muscle is partly dependent on calcineurin activation

Journal of Cellular Physiology

Volumn 210, Issue 3, 2007, Pages 596-601

  Banzet, Sébastien ^a   Koulmann, Nathalie ^a   Sanchez, Hervé ^a   Serrurier, Bernard ^a   Peinnequin, André ^a   Alonso, Antonia ^a   Bigard, Xavier ^a  

^a CENTRE DE RECHERCHES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CARBOHYDRATE; CYCLOSPORIN A; GLYCOGEN; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN; PROTEIN MCIP 1; TACROLIMUS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXERCISE; EXHAUSTION; FEMALE; FUNCTIONAL PROTEOMICS; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; GLYCOGEN MUSCLE LEVEL; MUSCLE CONTRACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RAT; RAT STRAIN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SLOW MUSCLE; SOLEUS MUSCLE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TIME; TRANSCRIPTION REGULATION; TREADMILL EXERCISE; WESTERN BLOTTING;

ANIMALS; CALCINEURIN; CYCLOSPORINE; FEMALE; GLYCOGEN; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-6; MUSCLE CONTRACTION; MUSCLE FIBERS, SLOW-TWITCH; MUSCLE, SKELETAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, WISTAR; RNA, MESSENGER; TACROLIMUS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

RATTUS;

EID: 33846649567     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20854     Document Type: Article

References (37)

1. Abbott KL, Loss JR, II, Robida AM, Murphy TJ. 2000. Evidence that Galpha(q)-coupled receptor-induced interleukin-6 mRNA in vascular smooth muscle cells involves the nuclear factor of activated T cells. Mol Pharmacol 58:946-953.
2. Alzuherri H, Chang KC. 2003. Calcineurin activates NFκB in skeletal muscle C2C12 cells. Cell Signal 15:471-478.
3. Banzet S, Koulmann N, Simler N, Birot O, Sanchez H, Chapot R, Peinnequin A, Bigard X. 2005. Fibre-type specificity of interleukin-6 gene transcription during muscle contraction in rat: Association with calcineurin activity. J Physiol 566:839-847.
4. Bassel-Duby R, Olson EN. 2003. Role of calcineurin in striated muscle: Development, adaptation, and disease. Biochem Biophys Res Commun 311:1133-1141.
5. Bergmeyer HU. 1983. Methods of enzymatic analysis, Vol. VI. New York: Academics, pp 11-18.
6. Bigard X, Sanchez H, Zoll J, Mateo P, Rousseau V, Veksler V, Ventura-Clapier R. 2000. Calcineurin co-regulates contractile and metabolic components of slow muscle phenotype. J Biol Chem 275:19653-19660.
7. Chan MH, McGee SL, Watt MJ, Hargreaves M, Febbraio MA. 2004. Altering dietary nutrient intake that reduces glycogen content leads to phosphorylation of nuclear p38 MAP kinase in human skeletal muscle: Association with IL-6 gene transcription during contraction. FASEB J 18:1785-1787.
8. Chin ER, Olson EN, Richardson JA, Yang Q, Humphries C, Shelton JM, Wu H, Zhu W, Bassel-Duby R, Williams RS. 1998. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev 12:2499-2509.
9. Ducreux S, Zorzato F, Muller C, Sewry C, Muntoni F, Quinlivan R, Restagno G, Girard T, Treves S. 2004. Effect of ryanodine receptor mutations on interleukin-6 release and intracellular calcium homeostasis in human myotubes from malignant hyperthermia-susceptible individuals and patients affected by central core disease. J Biol Chem 279:43838-43846.
10. Febbraio MA, Pedersen BK. 2002. Muscle-derived interleukin-6: Mechanisms for activation and possible biological roles. FASEB J 16:1335-1347.
11. Febbraio MA, Hiscock N, Sacchetti M, Fischer CP, Pedersen BK. 2004. Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes 53:1643-1648.
12. Frantz B, Nordby EC, Bren G, Steffan N, Paya CV, Kincaid RL, Tocci MJ, O'Keefe SJ, O'Neill EA. 1994. Calcineurin acts in synergy with PMA to inactivate IκB/MAD3, an inhibitor of NF-κB. EMBO J 13:861-870.
13. Frost RA, Nystrom GJ, Lang CH. 2003. Lipopolysaccharide and proinflammatory cytokines stimulate interleukin-6 expression in C2C12 myoblasts: Role of the Jun NH2-terminal kinase. Am J Physiol Regul Integr Comp Physiol 285:R1153-R1164.
14. Frost RA, Nystrom GJ, Lang CH. 2004. Epinephrine stimulates IL-6 expression in skeletal muscle and C2C12 myoblasts: Role of c-Jun NH2-terminal kinase and histone deacetylase activity. Am J Physiol Endocrinol Metab 286:E809-E817.
15. Hiscock N, Chan MH, Bisucci T, Darby IA, Febbraio MA. 2004. Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: Evidence of fiber type specificity. FASEB J 18:992-994.
16. Holmes AG, Watt MJ, Carey AL, Febbraio MA. 2004. Ionomycin, but not physiologic doses of epinephrine, stimulates skeletal muscle interleukin-6 mRNA expression and protein release. Metabolism 53:1492-1495.
17. Keller C, Steensberg A, Pilegaard H, Osada T, Saltin B, Pedersen BK, Neufer PD. 2001. Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: Influence of muscle glycogen content. FASEB J 15:2748-2750.
18. Kosmidou I, Vassilakopoulos T, Xagorari A, Zakynthinos S, Papapetropoulos A, Roussos C. 2002. Production of interleukin-6 by skeletal myotubes: Role of reactive oxygen species. Am J Respir Cell Mol Biol 26:587-593.
19. Koulmann N, Bigard AX. 2006 Interaction between signalling pathways involved in skeletal muscle responses to endurance exercise. Pflüg Arch 452:125-139.
20. Liu Y, Cseresnyés Z, Randall WR, Schneider MF. 2001. Activity-dependent nuclear translocation and intranuclear distribution of NFATc in adult skeletal muscle fibers. J Cell Biol 155:27-39.
21. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
22. Long YC, Widegren U, Zierath JR. 2004. Exercise-induced mitogen-activated protein kinase signalling in skeletal muscle. Proc Nutr Soc 63:227-232.
23. Luo G, Hershko DD, Robb BW, Wray CJ, Hasselgren PO. 2003. IL-1beta stimulates IL-6 production in cultured skeletal muscle cells through activation of MAP kinase signaling pathway and NF-kappa B. Am J Physiol Regul Integr Comp Physiol 284:R1249-R1254.
24. Mercier JG, Hokanson JF, Brooks GA. 1995. Effects of cyclosporine A on skeletal muscle mitochondrial respiration and endurance time in rats. Am J Respir Crit Care Med 151:1532-1536.
25. Molkentin JD. 2004. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc Res 63:467-475.
26. Norrbom J, Sundberg CJ, Ameln H, Kraus WE, Jansson E, Gustafsson T. 2004. PGC-1alpha mRNA expression is influenced by metabolic perturbation in exercising human skeletal muscle. J Appl Physiol 96:189-194.
27. Parsons SA, Millay DP, Wilkins BJ, Bueno OF, Tsika GL, Neilson JR, Liberatore CM, Yutzey KE, Crabtree GR, Tsika RW, Molkentin JD. 2004. Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy. J Biol Chem 279:26192-26200.
28. Peinnequin A, Mouret C, Birot O, Alonso A, Mathieu J, Clarencon D, Agay D, Chancerelle Y, Multon E. 2004. Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol 5:3.
29. Petersen EW, Carey AL, Sacchetti M, Steinberg GR, Macaulay SL, Febbraio MA, Pedersen BK. 2005. Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro. Am J Physiol 288:E155-E162.
30. Rothermel BA, Vega RB, Williams RS. 2003. The role of modulatory calcineurin interacting proteins in calcinerin signaling. Trends Cardiovasc Med 13:15-21.
31. Sanchez-Perez I, Rodriguez-Hernandez CJ, Manguan-Garcia C, Torres A, Perona R, Murgia JR. 2004. FK506 sensitizes mammalian cells to high osmolarity by modulating p38 MAP kinase activation. Cell Mol Life Sci 61:700-708.
32. Sasakawa T, Sasakawa Y, Ohkubo Y, Mutoh S. 2005. FK506 ameliorates spontaneous locomotor activity in collagen-induced arthritis: Implication of distinct effect from suppression of inflammation. Int Immunopharmacol 5:503-510.
33. Shen T, Liu Y, Cseresnyés Z, Hawkins A, Randall WR, Schneider MF. 2006. Activity- and calcineurin-independent nuclear shuttling of NFATc1, but not NFATc3, in adult skeletal muscle fibers. Mol Biol Cell 17:1570-1582.
34. Steensberg A, Febbraio MA, Osada T, Schjerling P, van Hall G, Saltin B, Pedersen BK. 2001. Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J Physiol 537:633-639.
35. Van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Moller K, Saltin B, Febbraio MA, Pedersen BK. 2003. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88:3005-3010.
36. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: research 0034.1-0034.11.
37. Yang J, Rothermel B, Vega RB, Frey N, McKinsey TA, Olson EN, Bassel-Duby R, Williams RS. 2000. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res 87:E61-E68.